PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 299 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $992 | -2.4% | 34,683 | -0.3% | 0.00% | 0.0% |
Q1 2024 | $1,016 | -13.5% | 34,783 | 0.0% | 0.00% | -33.3% |
Q4 2023 | $1,174 | +10.0% | 34,783 | 0.0% | 0.00% | 0.0% |
Q3 2023 | $1,067 | -24.1% | 34,783 | -0.9% | 0.00% | 0.0% |
Q2 2023 | $1,406 | -3.2% | 35,083 | -1.4% | 0.00% | 0.0% |
Q1 2023 | $1,452 | +4.9% | 35,583 | -0.7% | 0.00% | 0.0% |
Q4 2022 | $1,384 | -99.9% | 35,836 | +0.3% | 0.00% | -40.0% |
Q3 2022 | $1,901,000 | -8.5% | 35,736 | +0.3% | 0.01% | 0.0% |
Q2 2022 | $2,078,000 | -23.4% | 35,636 | +0.3% | 0.01% | -16.7% |
Q1 2022 | $2,712,000 | +26.8% | 35,536 | 0.0% | 0.01% | +50.0% |
Q4 2021 | $2,138,000 | +7.4% | 35,536 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $1,990,000 | -8.2% | 35,536 | -0.5% | 0.00% | -20.0% |
Q2 2021 | $2,167,000 | -13.4% | 35,709 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $2,503,000 | +19.5% | 35,709 | +2.0% | 0.01% | 0.0% |
Q4 2020 | $2,095,000 | -0.5% | 35,011 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $2,105,000 | +11.4% | 35,011 | -2.8% | 0.01% | 0.0% |
Q2 2020 | $1,890,000 | +57.0% | 36,012 | +0.3% | 0.01% | +25.0% |
Q1 2020 | $1,204,000 | -17.8% | 35,912 | +11.1% | 0.00% | +33.3% |
Q4 2019 | $1,464,000 | +133.5% | 32,312 | +96.1% | 0.00% | +50.0% |
Q3 2019 | $627,000 | – | 16,475 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 273,000 | $8,818,000 | 6.24% |
Standard Investments LLC | 775,388 | $25,045,000 | 4.58% |
ARMISTICE CAPITAL, LLC | 400,000 | $12,920,000 | 3.06% |
HealthCor Management, L.P. | 1,575,000 | $50,873,000 | 2.88% |
DARUMA CAPITAL MANAGEMENT LLC | 1,219,642 | $39,394,000 | 2.24% |
Consonance Capital Management LP | 631,805 | $20,407,000 | 2.24% |
Rock Springs Capital Management LP | 713,000 | $23,030,000 | 1.54% |
Biondo Investment Advisors, LLC | 142,473 | $4,602,000 | 1.52% |
Opus Point Partners Management, LLC | 50,000 | $1,615,000 | 1.29% |
Partner Investment Management, L.P. | 26,690 | $862,000 | 1.14% |